Rosuvastatin augments dipyridamole induced vasodilation by increased adenosine receptor stimulation
- Registry ID
- EUCTR2007-004762-40
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE4
- Sponsor
- Dept. Pharmacology and Toxicology
- Start date
- 2007-09-21
- Last update
- 2026-08-16
Conditions
- Ischemia-reperfusion injury
Summary
To determine whether a one-week treatment with rosuvastatin augments dipyridamole-induced forearm vasodilation by increased adenosine receptor stimulation.
Locations
Related clinical trials
View on source registry